Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Pds Biotechnology Corp (NQ: PDSB ) 2.010 -0.240 (-10.67%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 15, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Pds Biotechnology Corp < Previous 1 2 3 4 5 6 Next > Where PDS Biotechnology Stands With Analysts March 30, 2023 Via Benzinga Earnings Preview For PDS Biotechnology March 27, 2023 Via Benzinga 3 Deeply Undervalued Stocks That Could Double Your Money February 15, 2023 These cutting-edge biotech stocks hold tremendous upside potential. Via The Motley Fool Nasdaq Down 1%; Crude Oil Falls Sharply January 03, 2023 U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping over 100 points on Tuesday. Via Benzinga US Stocks Turn Lower; Dow Falls 100 Points January 03, 2023 U.S. stocks turned lower midway through trading, with the Dow Jones dropping around 100 points on Tuesday. Via Benzinga PDS Biotech, Merck Germany Enter Licensing Pact For Investigational Cancer Treatment January 03, 2023 Via Benzinga PDS Biotechnology, Pulmonx, Tesla And Some Other Big Stocks Moving Lower On Tuesday January 03, 2023 U.S. stocks traded lower, with the Nasdaq Composite dropping around 50 points on Tuesday. Here are some big stocks recording losses in today’s session. Via Benzinga PDS Biotechnology Triple Combo Therapy Shows 21 Months Of Overall Survival In HPV-Positive Cancers December 28, 2022 Via Benzinga Why Horizon Global Shares Are Trading Higher By Over 340%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session January 03, 2023 Gainers Horizon Global Corporation (NYSE: HZN) shares surged 341% to $1.7161 after the company announced it will be acquired by First Brands Group. Via Benzinga 20 Favorite Biotech & Medical Stocks For 2023 December 28, 2022 The way these stocks are setting up, many of them look great and will be at the forefront this coming year. Via Talk Markets In a New Audio Interview, Toni Loudenbeck of Traders News Source Interviews Dr. Frank Bedu-Addo, CEO PDS Biotechnology Corporation December 05, 2022 Via ACCESSWIRE PDS Biotech Posts 100% Clinical Response In Cervical Cancer Patients For Its Lead Program November 14, 2022 Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session November 22, 2022 Via Benzinga PDS Biotechnology To Rally Around 129%? Here Are 5 Other Price Target Changes For Tuesday November 15, 2022 Via Benzinga Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday November 15, 2022 Gainers Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus... Via Benzinga Miniso Group, Monday.com And Other Big Gainers From Monday November 15, 2022 U.S. stocks closed lower on Monday, with the Dow Jones dropping more than 200 points. Here is the list of some big stocks recording gains in the previous session. Via Benzinga Dow Surges 150 Points; Crude Oil Falls Sharply November 14, 2022 U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining around 150 points on Monday. Via Benzinga Why PDS Biotechnology Stock Is Soaring Today November 14, 2022 PDS Biotechnology Corp (NASDAQ: PDSB) shares are up nearly 30% Monday after the company announced a 100% clinical response in cervical cancer patients in preliminary data from the IMMUNOCERV Phase 2... Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session November 14, 2022 Gainers Via Benzinga Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday's Mid-Day Session November 14, 2022 Gainers Freight Technologies, Inc. (NASDAQ: FRGT) shares surged 137% to $0.4901 after analysts at Chardan Capital initiated coverage of the stock with a $2.25 price target. Via Benzinga US Stocks Mostly Lower; Nasdaq Drops Over 100 Points November 14, 2022 U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping more than 100 points on Monday. Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session November 14, 2022 Gainers Opiant Pharma (NASDAQ:OPNT) stock rose 118.3% to $20.74 during Monday's pre-market session. The market value of their outstanding shares is at $107.1 million. As per the press release, Q3... Via Benzinga Earnings Scheduled For November 14, 2022 November 14, 2022 Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million. Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session November 11, 2022 Gainers Cosmos Holdings (NASDAQ:COSM) shares increased by 27.9% to $0.15 during Friday's pre-market session. The market value of their outstanding shares is at $12.3 million. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022 November 01, 2022 Upgrades Via Benzinga Why Super Micro Computer Shares Jumped Over 10%; Here Are 73 Biggest Movers From Yesterday October 21, 2022 Gainers NextPlay Technologies, Inc. (NASDAQ: NXTP) shares climbed 107.3% to close at $0.4138 on Thursday after the company announced its NextFintech division received commitment for a $15 million... Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session October 20, 2022 Gainers Via Benzinga Why Ericsson Shares Are Trading Lower? Here Are 56 Stocks Moving In Thursday's Mid-Day Session October 20, 2022 Gainers NextPlay Technologies, Inc. (NASDAQ: NXTP) shares jumped 126% to $0.4525 after the company announced its NextFintech division received commitment for a $15 million strategic investment. Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session October 11, 2022 Gainers Via Benzinga PDS Biotech Highlights Expanded Data From PDS0101 Triple Combination Trial In HPV-Positive Cancers October 11, 2022 Via Benzinga < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
